Hideaki Nakamura

8.7k total citations · 2 hit papers
94 papers, 7.3k citations indexed

About

Hideaki Nakamura is a scholar working on Molecular Biology, Materials Chemistry and Biomaterials. According to data from OpenAlex, Hideaki Nakamura has authored 94 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 20 papers in Materials Chemistry and 17 papers in Biomaterials. Recurrent topics in Hideaki Nakamura's work include Nanoparticle-Based Drug Delivery (16 papers), Nanoplatforms for cancer theranostics (15 papers) and Lanthanide and Transition Metal Complexes (9 papers). Hideaki Nakamura is often cited by papers focused on Nanoparticle-Based Drug Delivery (16 papers), Nanoplatforms for cancer theranostics (15 papers) and Lanthanide and Transition Metal Complexes (9 papers). Hideaki Nakamura collaborates with scholars based in Japan, Czechia and United States. Hideaki Nakamura's co-authors include Jun Fang, Hiroshi Maeda, Kenji Tsukigawa, Long Liao, Karel Ulbrich, Tomáš Etrych, Petr Chytil, Haibo Qin, Masaki Otagiri and Khaled Greish and has published in prestigious journals such as Nucleic Acids Research, Blood and Biomaterials.

In The Last Decade

Hideaki Nakamura

90 papers receiving 7.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect

2010 2.9k citations Jun Fang, Hideaki Nakamura et al. profile →
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo

2012 2.0k citations Hiroshi Maeda, Hideaki Nakamura et al. profile →

Peers

Countries citing papers authored by Hideaki Nakamura

Since Specialization

Citations

This map shows the geographic impact of Hideaki Nakamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideaki Nakamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideaki Nakamura more than expected).

Fields of papers citing papers by Hideaki Nakamura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideaki Nakamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideaki Nakamura. The network helps show where Hideaki Nakamura may publish in the future.

Co-authorship network of co-authors of Hideaki Nakamura

This figure shows the co-authorship network connecting the top 25 collaborators of Hideaki Nakamura. A scholar is included among the top collaborators of Hideaki Nakamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideaki Nakamura. Hideaki Nakamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chemical modification of bradykinin-polymer conjugates for optimum delivery of nanomedicines to tumors 2024 ·Nanomedicine Nanotechnology Biology and Medicine ·(unknown), Hideaki Nakamura, (unknown), Tomáš Etrych, Mamoru Haratake	2
2	Highly effective anti-tumor nanomedicines based on HPMA copolymer conjugates with pirarubicin prepared by controlled RAFT polymerization 2020 ·Acta Biomaterialia ·Eva Randárová, Hideaki Nakamura, (unknown), Martin Studenovský, Mamoru Haratake, Jun Fang, Petr Chytil, Tomáš Etrych	22
3	In vivo Efficacy and Safety Evaluation of Lactosyl-β-cyclodextrin as a Therapeutic Agent for Hepatomegaly in Niemann-Pick Type C Disease 2019 ·Nanomaterials ·Yuki Maeda, Keiichi Motoyama, (unknown), Taishi Higashi, Risako Onodera, Hideaki Nakamura, Toru Takeo, Naomi Nakagata, (unknown), Yoichi Ishitsuka, Yuki Kondo, Tetsumi Irie, Takumi Era, Hidetoshi Arima	13
4	DEVELOPMENT OF BRIDGE INSPECTION SYSTEM REGADING WITH ACCESSING INSPECTION DATA USING AUGMENTED REALITY 2019 ·Journal of Japan Society of Civil Engineers Ser F3 (Civil Engineering Informatics) ·(unknown), (unknown), Hideaki Nakamura, Kei Kawamura	0
5	The role of vimentin in the tumor marker Nup88-dependent multinucleated phenotype 2018 ·BMC Cancer ·Masaki Makise, Hideaki Nakamura, Akihiko Kuniyasu	14
6	HPMA Copolymer-Conjugated Pirarubicin in Multimodal Treatment of a Patient with Stage IV Prostate Cancer and Extensive Lung and Bone Metastases 2015 ·Targeted Oncology ·(unknown), Shintaro Yanazume, Hideaki Nakamura, Tomáš Etrych, Petr Chytil, Karel Ulbrich, Jun Fang, (unknown), Tsutomu Douchi, Hiroaki Kobayashi, (unknown), Hiroshi Maeda	77
7	pH-sensitive polymeric cisplatin-ion complex with styrene-maleic acid copolymer exhibits tumor-selective drug delivery and antitumor activity as a result of the enhanced permeability and retention effect 2015 ·Colloids and Surfaces B Biointerfaces ·(unknown), Hideaki Nakamura, Jun Fang, Kenji Tsukigawa, Khaled Greish, Hiroyuki Furukawa, Hiroshi Maeda	40
8	Therapeutic Potential of Pegylated Hemin for Reactive Oxygen Species-Related Diseases via Induction of Heme Oxygenase-1: Results from a Rat Hepatic Ischemia/Reperfusion Injury Model 2011 ·Journal of Pharmacology and Experimental Therapeutics ·Jun Fang, Haibo Qin, Takahiro Seki, Hideaki Nakamura, Kenji Tsukigawa, Takashi Shin, Hiroshi Maeda	39
9	4-Amino-6-hydroxypyrazolo [3,4-d]pyrimidine (AHPP) conjugated PEG micelles: Water soluble polymeric xanthine oxidase inhibitor 2011 ·Journal of drug targeting ·Gahininath Y. Bharate, Jun Fang, Hideaki Nakamura, Haibo Qin, Seiji Shinkai, Hiroshi Maeda	5
10	Production of Rat Monoclonal Antibodies Against RNA-Binding Protein Hzf 2010 ·Hybridoma ·Hideaki Nakamura, Azusa Asai, Mitsuo Maruyama, Masataka Sugimoto	1
11	AT Cells Show Dissimilar Hypersensitivity to Heavy-Ion and X-rays Irradiation 2010 ·Journal of Radiation Research ·(unknown), Hideaki Nakamura, Makoto Adachi, Kei Ijichi, Yoshihiro Yasui, Noriko Saito, Masao Suzuki, Kenichi Kurita, Kanji Ishizaki	15
12	hTERT-Immortalized Cells Useful for Analyzing Effects of Low-Dose-Rate Radiation on Human Cells 2008 ·Journal of Radiation Research ·Hideaki Nakamura	8
13	Sp1‐dependent regulation of Myeloid Elf‐1 like factor in human epithelial cells 2005 ·FEBS Letters ·Tomoaki Koga, Mary Ann Suico, Hideaki Nakamura, Manabu Taura, Zhuo Lü, Tsuyoshi Shuto, Tsukasa Okiyoneda, Hirofumi Kai	25
14	Cytotoxic and Mutagenic Effects of Chronic Low-Dose-Rate Irradiation onTERT-Immortalized Human Cells 2005 ·Radiation Research ·Hideaki Nakamura, Hiroko Fukami, Yuko Hayashi, Akira Tachibana, Shigekazu Nakatsugawa, Michinari Hamaguchi, Kanji Ishizaki	16
15	No Induction of p53 Phosphorylation and Few Focus Formation of Phosphorylated H2AX Suggest Efficient Repair of DNA Damage During Chronic Low-dose-rate Irradiation in Human Cells 2004 ·Journal of Radiation Research ·Kanji Ishizaki, Yuko Hayashi, Hideaki Nakamura, Yoshihiro Yasui, Kenshi Komatsu, Akira Tachibana	44
16	Selective accumulation of ALA-induced PpIX and photodynamic effect in chemically induced hepatocellular carcinoma 2003 ·British Journal of Cancer ·(unknown), (unknown), Yoshimasa Kobayashi, S Baba, Eiji Kohno, Tsunehisa Kawasaki, Yutaka Fujise, Hideaki Nakamura	40
17	Simultaneous Treatment With Benzyl Isothiocyanate, a Strong Bladder Promoter, Inhibits Rat Urinary Bladder Carcinogenesis by N-Butyl-N-(4-Hydroxybutyl)Nitrosamine 2002 ·Nutrition and Cancer ·Kazushi Okazaki, Megumi Yamagishi, Hwa–Young Son, Takayoshi Imazawa, Fumio Furukawa, Hideaki Nakamura, Akiyoshi Nishikawa, Toshiaki Masegi, Masao Hirose	25
18	Oral toxicity of a tocotrienol preparation in rats 2001 ·Food and Chemical Toxicology ·Hideaki Nakamura, Fumio Furukawa, Akiyoshi Nishikawa, Mutsumi Miyauchi, Hwa–Young Son, Takayoshi Imazawa, Masamichi Hirose	52
19	Nucleotide sequence of the human bone marrow serine protease (medullasin) gene 1987 ·Nucleic Acids Research ·Hideaki Nakamura, Kunihisa Okano, Yoshitsugu Aoki, Hirohiko M. Shimizu, Masanobu Naruto	13
20	Enzymatic Detection of X-ray-induced Strand Breaks in Nuclear DNA on Sections of Mouse Tissue 1976 ·International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine ·Hideaki Nakamura, T. Morita, S. Yoshida	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact